
Zhongchao Inc.
ZCMDNASDAQHealthcareMedical - Healthcare Information Services
Previous close
$0.9285
−$0.0317 · -3.30%
ZCMD company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
47
Fair Value
Momentum
42
Neutral
Sentiment
51
Mixed
Risk resilience
37
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteZhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Weiguang Yang
- Listed since
- Feb 24, 2020
- Employees
- 33
Market position
Day range
Current $0.9285
52-week range
Current $0.9285
- Open
- $0.9501
- Previous close
- $0.9602
- Volume
- 323.15K
- 0.07× average
- Average volume
- 4.51M
- Average daily volume
- Market cap
- 32.25K USD
- Beta
- -0.01
- Market reference 1
- 50-day average
- $1.4854
- -37.49% below average
- 200-day average
- $198.26
- -99.53% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 4.23M USD
- P/E (TTM)
- -0.01×
- P/B (TTM)
- 0×
- P/S (TTM)
- 0×
- EV / EBITDA
- -0.78×
- Earnings yield
- -51.28%
- Free cash flow yield
- 5.63%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 43.84%
- Operating margin
- -54.43%
- Net margin
- -55.47%
- Return on equity
- -33.87%
- Return on assets
- -25.95%
- Return on invested capital
- -27.14%
Financial health
- Debt / equity
- 0×
- Current ratio
- 11.11×
- Altman Z-score
- 0.3
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.37M USD | 15.86M USD | 19.43M USD | 14.15M USD | 16.3M USD |
| Cost of goods sold | 6.54M USD | 6.95M USD | 10.92M USD | 7.79M USD | 6.86M USD |
| Gross profit | 4.83M USD | 8.91M USD | 8.51M USD | 6.36M USD | 9.44M USD |
| Research and development | 8.09K USD | 252.45K USD | 514.41K USD | 411.52K USD | 758.88K USD |
| Selling, general, and administrative | 11.01M USD | 9M USD | 13.41M USD | 8.9M USD | 9M USD |
| Operating expenses | 11.02M USD | 9.25M USD | 21.8M USD | 9.31M USD | 9.76M USD |
| Interest income | 343.13K USD | 243.01K USD | 237.05K USD | 142.01K USD | 175.99K USD |
| Depreciation and amortization | 321.67K USD | 428.36K USD | 923.61K USD | 730.31K USD | 702.98K USD |
| Operating income | −6.19M USD | −341.27K USD | −13.28M USD | −2.95M USD | −320.74K USD |
| Net income | −6.31M USD | −643.23K USD | −11.34M USD | −2.94M USD | 238.67K USD |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- -1.43
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
ZCMD news
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 29, 2026 | 1:3 | — | — |
Stock split | Jun 8, 2026 | 1:31 | — | — |
Stock split | Mar 2, 2026 | 1:8 | — | — |
Stock split | Feb 29, 2024 | 1:10 | — | — |
Effective Jun 29, 2026
1:3
Effective Jun 8, 2026
1:31
Effective Mar 2, 2026
1:8
Effective Feb 29, 2024
1:10
ZCMD peers
Continue in GoAI
Research ZCMDresearch.disclaimer










